Literature DB >> 19141766

Treating drug abuse and addiction in the criminal justice system: improving public health and safety.

Redonna K Chandler1, Bennett W Fletcher, Nora D Volkow.   

Abstract

Despite increasing evidence that addiction is a treatable disease of the brain, most individuals do not receive treatment. Involvement in the criminal justice system often results from illegal drug-seeking behavior and participation in illegal activities that reflect, in part, disrupted behavior ensuing from brain changes triggered by repeated drug use. Treating drug-involved offenders provides a unique opportunity to decrease substance abuse and reduce associated criminal behavior. Emerging neuroscience has the potential to transform traditional sanction-oriented public safety approaches by providing new therapeutic strategies against addiction that could be used in the criminal justice system. We summarize relevant neuroscientific findings and evidence-based principles of addiction treatment that, if implemented in the criminal justice system, could help improve public heath and reduce criminal behavior.

Entities:  

Mesh:

Year:  2009        PMID: 19141766      PMCID: PMC2681083          DOI: 10.1001/jama.2008.976

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  54 in total

Review 1.  Molecular genetic underpinnings of human substance abuse vulnerability: likely contributions to understanding addiction as a mnemonic process.

Authors:  George R Uhl
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

Review 2.  Pharmacotherapy treatment in substance-dependent correctional populations: a review.

Authors:  Karen L Cropsey; Gabriela C Villalobos; Christina L St Clair
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

3.  Co-occurring disorders among mentally ill jail detainees. Implications for public policy.

Authors:  K M Abram; L A Teplin
Journal:  Am Psychol       Date:  1991-10

4.  Linkage with methadone treatment upon release from incarceration: a promising opportunity.

Authors:  Josiah D Rich; Michelle McKenzie; David C Shield; Francis A Wolf; R Garrett Key; Michael Poshkus; Jennifer Clarke
Journal:  J Addict Dis       Date:  2005

5.  Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Jean Logan; Anna-Rose Childress; Millard Jayne; Yeming Ma; Christopher Wong
Journal:  J Neurosci       Date:  2006-06-14       Impact factor: 6.167

Review 6.  Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences.

Authors:  Nora D Volkow; Ting-Kai Li
Journal:  Pharmacol Ther       Date:  2005-10       Impact factor: 12.310

7.  Treatment of chronic hepatitis C in a state correctional facility.

Authors:  Scott A Allen; Anne C Spaulding; Albert M Osei; Lynn E Taylor; Asya M Cabral; Josiah D Rich
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

8.  A Study of Methadone Maintenance For Male Prisoners: 3-Month Postrelease Outcomes.

Authors:  Timothy W Kinlock; Michael S Gordon; Robert P Schwartz; Kevin E O'Grady
Journal:  Crim Justice Behav       Date:  2008

9.  The burden of complex genetics in brain disorders.

Authors:  George R Uhl; Robert W Grow
Journal:  Arch Gen Psychiatry       Date:  2004-03

Review 10.  The role of orbitofrontal cortex in decision making: a component process account.

Authors:  Lesley K Fellows
Journal:  Ann N Y Acad Sci       Date:  2007-09-10       Impact factor: 5.691

View more
  160 in total

1.  Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status.

Authors:  Shannon Gwin Mitchell; Jan Gryczynski; Sharon M Kelly; Kevin E O'Grady; Jerome H Jaffe; Yngvild K Olsen; Robert P Schwartz
Journal:  J Drug Issues       Date:  2014-01

2.  Clinical implications of drug abuse epidemiology.

Authors:  Jeffrey D Schulden; Marsha F Lopez; Wilson M Compton
Journal:  Psychiatr Clin North Am       Date:  2012-06

3.  Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Authors:  Jaimie P Meyer; Javier Cepeda; Johnny Wu; Robert L Trestman; Frederick L Altice; Sandra A Springer
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

4.  A Pilot Study of a Brief Motivational Intervention for Incarcerated Drinkers.

Authors:  Mandy D Owens; Barbara S McCrady
Journal:  J Subst Abuse Treat       Date:  2016-05-26

5.  Receipt of Pharmacotherapy for Alcohol Use Disorder by Male Justice-Involved U.S. Veterans Health Administration Patients.

Authors:  Andrea K Finlay; Ingrid Binswanger; Christine Timko; Joel Rosenthal; Sean Clark; Jessica Blue-Howells; Jim McGuire; Hildi Hagedorn; Jessie Wong; James Van Campen; Alex H S Harris
Journal:  Crim Justice Policy Rev       Date:  2016-04-18

6.  Access to Recovery and Recidivism Among Former Prison Inmates.

Authors:  Bradley Ray; Eric Grommon; Victoria Buchanan; Brittany Brown; Dennis P Watson
Journal:  Int J Offender Ther Comp Criminol       Date:  2015-09-17

Review 7.  Functional Neurocircuits and Neuroimaging Biomarkers of Tobacco Use Disorder.

Authors:  Matthew T Sutherland; Elliot A Stein
Journal:  Trends Mol Med       Date:  2018-02       Impact factor: 11.951

8.  Alcohol use disorders and antiretroviral therapy among prisoners in Argentina.

Authors:  Michael Alpert; Jeffrey A Wickersham; Mariana Vázquez; Frederick L Altice
Journal:  Int J Prison Health       Date:  2013

9.  Medication-Assisted Treatment and Violent Outcomes in Community-Based Offenders with Alcohol and Drug Use Problems.

Authors:  Sarah L Desmarais; Julie S Gray; Candalyn B Rade; Amy M Cohn; Stephen Doherty; Kevin Knight
Journal:  Psychol Violence       Date:  2016-03-24

10.  Criminal Justice Professionals' Attitudes Toward Mental Illness and Substance Use.

Authors:  Evan M Lowder; Bradley R Ray; Jeffrey A Gruenewald
Journal:  Community Ment Health J       Date:  2019-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.